Today, Maesyn is happy.
That may sound like a simple statement, but for his family, it carries the weight of miracles, resilience, and gratitude that is almost impossible to put into words. After months of fear, uncertainty, and watching their child fight battles no baby should ever face, “happy” is everything..

Maesyn has been having some truly great days. Not just stable days, but days filled with progress. Days marked by real strides toward being extubated. Days where his tiny body is responding, healing, and showing strength in ways that once felt unimaginable. His bloodwork looks good. His ventilation is being weaned successfully. And perhaps most importantly, he is comfortable—something that, for a long time, felt heartbreakingly out of reach.
For his mother, sitting beside him and holding him now feels overwhelming in the most beautiful way.
“I am overwhelmingly grateful,” she says. Grateful not only for how well Maesyn is doing, but for the medical technology that is keeping him alive. For the treatments, the innovation, and the expertise that make this moment possible.
Just five or ten years ago, Maesyn’s diagnosis would have been a death sentence.

There was no technology capable of supporting babies like him. No devices to give his heart the help it desperately needs. No path forward filled with cautious hope instead of final goodbyes. Today, because of extraordinary advances in medicine, Maesyn is here—fighting, improving, and proving what modern science and relentless love can achieve together.
Maesyn is supported by a ventricular assist device, or VAD, helping his single-ventricle heart do what it cannot do alone. And his case is not just rare—it is historic.
He is only the
second hybrid palliation baby or child ever placed on a single-ventricle VAD at Seattle Children’s Hospital.
That fact alone is staggering.
Even more astonishing is this: he is doing well.
He has never looked this good—in every aspect. His labs are stable. His lungs are improving. His comfort level, once painfully elusive, has finally been achieved. The machine that supports his heart has given him something priceless: time. Time to grow stronger. Time for his body to rest. Time for hope to take root.
This week, doctors introduced a new possibility.
There has been discussion about transitioning Maesyn to a smaller, more mobile version of the VAD. On the surface, that sounds promising—greater mobility, potentially more freedom, and a step toward a different phase of recovery. But there is a catch.
This device is part of a clinical trial.
And with that comes fear, questions, and the weight of impossible decisions. His mother is doing what any parent in her position would do—researching, asking questions, weighing every risk against every potential benefit. The thought that keeps surfacing is simple and deeply human:
he is doing so well right now… why rock the boat?
When you’ve fought this hard to reach stability, even positive change can feel terrifying.
There are no easy answers. Only careful consideration, trust in the medical team, and a parent’s instinct guiding every step. The coming days will involve conversations, data, and reflection as the family decides whether participating in this trial is the right choice for Maesyn.
For now, they are choosing gratitude.
Gratitude for a child who is smiling. For a body that is responding. For technology that once didn’t exist but now stands between life and loss. Gratitude for the doctors, nurses, researchers, and innovators who refuse to accept limitations as final answers.
And gratitude for community.
“This journey would be unbearable without the love and support we’ve received,” his mother shares. Friends. Family. Strangers who became prayer warriors. People who check in, donate, encourage, and hold space for hope on the hardest days. That support has mattered more than words can express.
Maesyn’s story is not finished. There are still unknowns ahead. Decisions yet to be made. Risks that cannot be ignored. But today—today—is a victory.
Today, Maesyn is comfortable. He is improving. He is held. He is loved.
And he is living proof of how far medicine has come, how powerful perseverance can be, and how miracles often arrive quietly—disguised as “good days” that once felt impossible.
For now, his family holds him close, breath by breath, heartbeat by heartbeat, choosing gratitude over fear and hope over despair.
And for everyone walking this road with them, one thing is clear:
Maesyn is doing something extraordinary.
And so is the world that is fighting alongside him.